Yoshiya Tanaka

ORCID: 0000-0002-0807-7139 · 4 papers in corpus
meta-analysis 2024
Effects of cyclophosphamide administration on ovarian dysfunction in pediatric patients with connective tissue diseases: A systematic scoping review
Modern rheumatology ·doi:10.1093/mr/roae060

OBJECTIVE: This systematic scoping review assess the effect of cyclophosphamide (CY) administration during childhood on ovarian function in patients with juvenile-onset connective tissue diseases. METHODS: A MEDLINE database search was con…

2024
MEDL Score: A Novel MRI Protocol That Can Predict Endometriosis With High Accuracy
·doi:10.1016/j.jmig.2024.09.069
rct 2023
Lower injection-site reactions and long-term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post-hoc analysis of a double-blind, randomized, phase III comparative study and its open-label extension in patients with rheumatoid arthritis
International journal of rheumatic diseases ·doi:10.1111/1756-185x.14462

AIM: YLB113 biosimilar was evaluated in an open-label extension single-arm study to assess long-term safety, efficacy, and immunogenicity in patients with rheumatoid arthritis (RA). We also report post-hoc results on the incidence of inject…

rct 2018
Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients
Arthritis research & therapy ·doi:10.1186/s13075-018-1536-9

BACKGROUND: Sirukumab, a high-affinity human monoclonal antibody that selectively binds to interleukin-6, has demonstrated efficacy in the treatment of rheumatoid arthritis (RA) in global phase 1 and phase 2 studies. The present study evalu…